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The	 frequency	with	which	melioidosis	 results	 from	 inhala-
tion	 rather	 than	 percutaneous	 inoculation	 or	 ingestion	 is	
unknown.	 We	 recovered	 Burkholderia pseudomallei from 
air	samples	at	the	residence	of	a	patient	with	presumptive	
inhalational	melioidosis	and	used	whole-genome	sequenc-
ing	 to	 link	 the	 environmental	 bacteria	 to	B. pseudomallei 
recovered	from	the	patient.
Melioidosis is thought to be caused predominantly by percutaneous inoculation with the bacterium 
Burkholderia pseudomallei; however, inhalation, aspira-
tion, and ingestion of the bacterium can also occur (1). 
Although an evidence-based clinical definition of inha-
lational melioidosis has recently been published (2), the 
proportion of melioidosis cases resulting from inhalation 
is unknown, and attempts to culture B. pseudomallei from 
air sampling in melioidosis-endemic regions have been 
largely unsuccessful (3). We recovered B. pseudomallei 
from air samples at the residence of a patient with pre-
sumptive inhalational melioidosis, and whole-genome 
sequencing linked the environmental bacteria to B. pseu-
domallei recovered from the patient.
The Study
A 47-year-old man with poorly controlled type 2 diabetes 
sought care at the Royal Darwin Hospital in the tropical 
north of the Northern Territory of Australia in January 2011 
after several weeks of increasing lethargy and 1 week of fe-
vers and cough. He was patient 692 in the Darwin Prospec-
tive Melioidosis Study (4), which is approved by the Hu-
man Research Ethics Committee of the Northern Territory 
Department of Health and the Menzies School of Health 
Research (approval 02/38). The patient’s chest radiograph 
(Figure 1, panel A) showed patchy pneumonia in the right 
lung and a large soft-tissue mass on the left side of the chest. 
A computed tomography scan (Figure 1, panel B) confirmed 
the mass to be a 7-cm × 6-cm loculated fluid collection in 
the anterior mediastinum contiguous with patchy bilateral 
pneumonia and associated with multiple enlarged mediasti-
nal lymph nodes and a pericardial effusion. Blood cultures 
collected at admission were positive for B. pseudomallei. 
The patient required initial management in the intensive 
care unit for his pneumonia, severe sepsis, and ketoacido-
sis. He received 45 days of intravenous antimicrobial drugs 
(meropenem for 11 days, followed by ceftazidime for 34 
days) in conjunction with oral trimethoprim/sulfamethoxa-
zole. After discharge, he received 15 subsequent weeks of 
eradication therapy with trimethoprim/sulfamethoxazole. 
At follow up, he has remained well 4 years after completing 
his melioidosis therapy.
The unusual finding of extensive mediastinal disease 
raised the possibility that the patient had inhalational meli-
oidosis. The patient described sitting most days outside his 
urban accommodation on an elevated and exposed mowed 
grassy area that overlooks ground sloping downhill to a 
rocky open drain, an environment that prompted the poten-
tial for targeted air sampling. The site was visited and en-
vironmental samples taken 6 weeks after the patient’s hos-
pital admission. During the sampling, squally rain showers 
occurred, accompanied by wind blowing up the hill and the 
drain flowing swiftly.
Two air samplings and 3 soil samples were collected. 
Each air collection entailed passing 1,000 L of air (50 L/
min for 20 min) through a portable microbiologic air sam-
pler (MD8 AirPort; Sartorius Stedim, Dandenong, Victo-
ria, Australia) with a disposable gelatin filter (3.0 µm) for 
sample collection. The air sampler was placed on a tripod 
at 1.0 m elevation above ground level and was protected 
by a secured, angled overhead umbrella to prevent direct 
rain contact. After each air sampling, the gelatin filter was 
placed in 30 mL of modified Ashdown selective broth and 
incubated at 37°C, with the broth supernatant plated onto 
Ashdown agar after 2 and 7 days (3). Soil samples were 
collected at ≈10 cm below the surface. Sterile water (20 
mL) was added to 20 g soil and shaken at 220 rpm for 48 
h at 37°C. After the soil samples were removed from the 
shaker and left to stand for 1–2 h, 10 mL of supernatant was 
placed in 30 mL of modified Ashdown selective broth and 
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incubated at 37°C; the broth supernatant was plated onto 
Ashdown agar after 2 and 7 days. Suspected B. pseudom-
allei colonies were confirmed by using the B. pseudomal-
lei–specific TTS1 real-time PCR, described previously (5).
B. pseudomallei was cultured from 1 of the 2 air sam-
ples and 1 of the 3 soil samples. Multilocus-sequence typ-
ing, completed by using standard methods (6), confirmed 
that 2 isolates from each of the positive air and soil samples 
and the isolate from the patient’s blood culture were all se-
quence type (ST) 562. To further resolve the relatedness 
of ST562 isolates, PCR-based, multilocus variable-number 
tandem-repeat analysis of 4 loci (MLVA-4) was performed 
as described (7) on the 4 environmental isolates, the pa-
tient’s blood culture isolate, and isolates from 13 other pa-
tients in the Darwin prospective study whose melioidosis 
was caused by ST562 B. pseudomallei. MLVA-4 catego-
rized the 18 ST562 isolates into 3 distinct types: 55 (n = 7), 
71 (n = 8), and 168 (n = 3). The isolate from patient 692, 
all 4 environmental isolates, and isolates from 2 of the 13 
other patients were MLVA-4 type 55.
To further define the relatedness of ST562 isolates, 
whole-genome sequencing was performed on 17 of the 18 
ST562 isolates for which MLVA-4 results were available; 
to reduce duplication and cost, 1 of the 2 B. pseudomallei 
isolates from air samples was not sequenced because it was 
clonal with the other air sample. Genomic DNA was ex-
tracted by using the QIAGEN DNeasy blood and tissue kit 
(QIAGEN, Chadstone, Victoria, Australia), as described 
(7). Samples were sequenced at Macrogen Inc. (Gasan-
dong, Seoul, South Korea) by using HiSeq 2000 (Illumina, 
San Diego, CA, USA). Genome analysis was performed 
with SPANDx version 2.3 (8) by using the ST562 strain 
MSHR4388 from the MLST database (http://bpseudomal-
lei.mlst.net/) as the reference genome.
Whole-genome identification of single-nucleotide poly-
morphisms (SNPs), followed by phylogenetic reconstruction 
Figure 1.	Clinical	studies	of	a	
patient	with	melioidosis,	Royal	
Darwin	Hospital,	Darwin,	Northern	
Territory,	Australia.	A)	Chest	
radiograph	shows	a	soft-tissue	
mass	associated	with	the	left	
side	of	the	mediastinum	and	
obscuring	the	aortic	arch.	B)	Chest	
computed	tomography	scan	shows	
a	large	loculated	mass	in	the	
anterior	mediastinum;	the	mass	is	
contiguous	with	multiple	enlarged	
mediastinal	lymph	nodes	and	with	
pulmonary	consolidation.
Figure 2.	Whole-genome	core	
orthologous	single-nucleotide	
polymorphism	(SNP)	phylogeny	of	
sequence	type	562	Burkholderia 
pseudomallei	isolates	from	a	
patient	with	melioidosis	and	from	
environmental	sampling	at	the	
patient’s	residence,	Darwin,	Northern	
Territory,	Australia.	MSHR4515	
(MLST	database	identifier,	http://
bpseudomallei.mlst.net/)	was	a	
blood	culture	isolate	from	the	index	
patient,	identified	as	patient	(P)	692	
(P692,	arrow).	Analysis	of	isolates	
from	13	other	patients	with	sequence	
type	562	are	also	shown	(identifiers	
begin	with	P).	Comparison	of	data	
for	SNPs	and	for	multilocus	variable-
number	tandem-repeat	analysis	
of	4	loci	(MLVA-4)	types	(shown	in	
parentheses)	supports	the	hypothesis	
that	P692	was	infected	from	
environmental	B. pseudomallei at his 
residence.	Consistency	index	=	1.
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by using maximum parsimony in PAUP 4.0b10 (9), showed 
that all ST562 isolates were closely related; only 26 SNPs 
were observed among all 17 genomes (Figure 2). The air iso-
late (added to the MLST database as MSHR4687) and the 
2 soil isolates (MSHR4681 and MSHR4682) obtained from 
the environment outside the residence of patient 692 were 
identical by whole-genome sequencing and differed from the 
blood culture isolate of patient 692 (MSHR4515) by only 3 
SNPs. These genetic similarities support the epidemiologic 
link between the air and soil B. pseudomallei and the pa-
tient’s infection.
Epidemiologic data from Australia, Singapore, and 
Taiwan support the hypothesis that inhalation may replace 
inoculation as the predominant route of B. pseudomallei 
transmission during severe weather events (e.g., tropi-
cal monsoonal storms, cyclones, and typhoons) (10–12). 
Similar clinical distinctions between percutaneous and 
inhalational infections are observed for anthrax, plague, 
and tularemia (4). Animal studies have also shown the 
potential importance of aerosol inhalation of B. pseudom-
allei with high lethality (13,14). Inhalational melioidosis 
is supported by the increasing recognition from computed 
tomography scanning that enlarged mediastinal lymph 
nodes are not uncommon in patients with severe melioi-
dosis pneumonia (4,10). Nevertheless, no direct evidence 
exists to confirm occurrence of inhalation of B. pseudom-
allei in melioidosis-endemic regions. A recent report from 
Taiwan documented an air sampling technique that uses 
a filtration real-time quantitative PCR method to quantify 
ambient B. pseudomallei DNA; high positive rates were 
found during typhoons (12).
Conclusions
B. pseudomallei was recovered from air samples taken 
outside the residence of a patient with clinical features 
consistent with inhalational melioidosis. Whole-genome 
sequencing linked the environmental B. pseudomallei 
to an isolate from the patient’s blood culture. These data 
provide evidence of aerosolization of B. pseudomallei dur-
ing stormy conditions in an endemic location and strong 
circumstantial evidence for inhalation of B. pseudomallei. 
The proportion of melioidosis cases resulting from inhala-
tion rather than percutaneous inoculation or ingestion re-
quires further study and is likely to vary substantially by 
location and season.
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